TEM8 in Oncogenesis: Protein Biology, Pre-Clinical Agents, and Clinical Rationale

por Kareff, Samuel A., Corbett, Virginia, Hallenbeck, Paul, Chauhan, Aman
Publicado 2023

Abscopal effect in pulmonary carcinoid tumor following ablative stereotactic body radiation therapy: a case report

por Kareff, Samuel A., Lischalk, Jonathan W., Krochmal, Rebecca, Kim, Chul
Publicado 2020

Current Landscape of Immunotherapy Trials Involving the Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Axis in Intrathoracic Tumors

por Kareff, Samuel A., Samtani, Suraj, Burotto, Mauricio, Prasad, Vinay, Kim, Chul
Publicado 2021

Efficacy and outcomes of ramucirumab and docetaxel in patients with metastatic non-small cell lung cancer after disease progression on immune checkpoint inhibitor therapy: Results...

por Kareff, Samuel A., Gawri, Kunal, Khan, Khadeja, Kwon, Deukwoo, Rodriguez, Estelamari, Lopes, Gilberto de Lima, Dawar, Richa
Publicado 2023

Disparities in Survival Due to Social Determinants of Health and Access to Treatment in US Patients With Operable Malignant Pleural Mesothelioma

por Alnajar, Ahmed, Kareff, Samuel A., Razi, Syed S., Rao, J. Sunil, De Lima Lopes, Gilberto, Nguyen, Dao M., Villamizar, Nestor, Rodriguez, Estelamari
Publicado 2023

Prevalence and Outcomes of COVID-19 among Hematology/Oncology Patients and Providers of a Community-Facing Health System during the B1.1.529 (“Omicron”) SARS-CoV-2 Variant Wave

por Kareff, Samuel A., Khan, Aliya, Barreto-Coelho, Priscila, Iyer, Sunil Girish, Pico, Brian, Stanchina, Michele, Dutcher, Giselle, Monteiro de Oliveira Novaes, José, Nallagangula, Aparna, Lopes, Gilberto
Publicado 2022